Doris Rau

890 total citations
14 papers, 673 citations indexed

About

Doris Rau is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology. According to data from OpenAlex, Doris Rau has authored 14 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 8 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Doris Rau's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (4 papers) and Protein purification and stability (3 papers). Doris Rau is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Immunotherapy and Immune Responses (4 papers) and Protein purification and stability (3 papers). Doris Rau collaborates with scholars based in Germany, United States and Switzerland. Doris Rau's co-authors include Peter Kufer, Patrick A. Baeuerle, Tobias Raum, Patrick Hoffmann, Susanne Mangold, Roman Kischel, Ralf Lutterbuese, Matthias Friedrich, Benno Rattel and Oliver S. Thomas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Doris Rau

14 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Rau Germany 11 435 370 267 263 75 14 673
Sabine Stienen Germany 13 491 1.1× 276 0.7× 307 1.1× 148 0.6× 69 0.9× 26 639
Jens De Vos Belgium 11 307 0.7× 695 1.9× 182 0.7× 417 1.6× 76 1.0× 11 890
Benjamin M. Larimer United States 12 454 1.0× 260 0.7× 293 1.1× 121 0.5× 110 1.5× 32 673
Casey W. Shuptrine United States 10 264 0.6× 179 0.5× 294 1.1× 225 0.9× 40 0.5× 13 588
Margit Jeschke Switzerland 9 309 0.7× 358 1.0× 375 1.4× 485 1.8× 92 1.2× 13 811
Ralf Lutterbüse Germany 11 681 1.6× 580 1.6× 447 1.7× 304 1.2× 74 1.0× 13 1.0k
Grit Lorenczewski Germany 13 746 1.7× 611 1.7× 441 1.7× 269 1.0× 81 1.1× 17 995
Thies Rösner Germany 16 202 0.5× 309 0.8× 463 1.7× 207 0.8× 38 0.5× 30 666
Amelia M. Huehls United States 10 488 1.1× 144 0.4× 166 0.6× 395 1.5× 52 0.7× 15 704
William R. Gwin United States 13 426 1.0× 125 0.3× 295 1.1× 272 1.0× 58 0.8× 34 669

Countries citing papers authored by Doris Rau

Since Specialization
Citations

This map shows the geographic impact of Doris Rau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Rau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Rau more than expected).

Fields of papers citing papers by Doris Rau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Rau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Rau. The network helps show where Doris Rau may publish in the future.

Co-authorship network of co-authors of Doris Rau

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Rau. A scholar is included among the top collaborators of Doris Rau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Rau. Doris Rau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Harmalkar, Ameya, Roshan Rao, Doris Rau, et al.. (2023). Toward generalizable prediction of antibody thermostability using machine learning on sequence and structure features. mAbs. 15(1). 2163584–2163584. 29 indexed citations
2.
Deegen, Petra, Oliver S. Thomas, Olivier Nolan-Stevaux, et al.. (2021). The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer. Clinical Cancer Research. 27(10). 2928–2937. 58 indexed citations
3.
Bailis, Julie M., Petra Deegen, Oliver S. Thomas, et al.. (2019). Preclinical evaluation of AMG 160, a next-generation bispecific T cell engager (BiTE) targeting the prostate-specific membrane antigen PSMA for metastatic castration-resistant prostate cancer (mCRPC).. Journal of Clinical Oncology. 37(7_suppl). 301–301. 17 indexed citations
4.
Friedrich, Matthias, Tobias Raum, Ralf Lutterbuese, et al.. (2012). Regression of Human Prostate Cancer Xenografts in Mice by AMG 212/BAY2010112, a Novel PSMA/CD3-Bispecific BiTE Antibody Cross-Reactive with Non-Human Primate Antigens. Molecular Cancer Therapeutics. 11(12). 2664–2673. 109 indexed citations
5.
Lutterbuese, Ralf, Matthias G. Friedrich, Roman Kischel, et al.. (2011). Abstract 4561: Preclinical characterization of MT112/BAY 2010112, a novel PSMA/CD3-bispecific BiTE antibody for the treatment of prostate cancer. Cancer Research. 71(8_Supplement). 4561–4561. 1 indexed citations
6.
Münz, Markus, Alexander Murr, Doris Rau, et al.. (2010). Side-by-side analysis of five clinically tested anti-EpCAM monoclonal antibodies. Cancer Cell International. 10(1). 44–44. 107 indexed citations
7.
Lutterbuese, Ralf, Tobias Raum, Roman Kischel, et al.. (2010). T cell-engaging BiTE antibodies specific for EGFR potently eliminate KRAS- and BRAF-mutated colorectal cancer cells. Proceedings of the National Academy of Sciences. 107(28). 12605–12610. 123 indexed citations
8.
Amann, Maria, Grit Lorenczewski, Klaus Brischwein, et al.. (2009). Antitumor Activity of an EpCAM/CD3-bispecific BiTE Antibody During Long-term Treatment of Mice in the Absence of T-cell Anergy and Sustained Cytokine Release. Journal of Immunotherapy. 32(5). 452–464. 43 indexed citations
9.
Raum, Tobias, Stefan Pflanz, Susanne Mangold, et al.. (2009). Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells. mAbs. 1(2). 115–127. 8 indexed citations
10.
Lutterbuese, Ralf, Tobias Raum, Roman Kischel, et al.. (2009). Potent Control of Tumor Growth by CEA/CD3-bispecific Single-chain Antibody Constructs That Are Not Competitively Inhibited by Soluble CEA. Journal of Immunotherapy. 32(4). 341–352. 64 indexed citations
11.
Mølhøj, Michael, Klaus Brischwein, Doris Rau, et al.. (2006). CD19-/CD3-bispecific antibody of the BiTE class is far superior to tandem diabody with respect to redirected tumor cell lysis. Molecular Immunology. 44(8). 1935–1943. 77 indexed citations
12.
Kramer, Karl, Doris Rau, & Bertold Hock. (2003). Comparison of affinity ranking and immunochemical key data as measure for molecular antibody evolution. Journal of Spectroscopy. 17(2-3). 355–365. 1 indexed citations
13.
Rau, Doris, Karl Kramer, & Bertold Hock. (2002). Cloning, functional expression and kinetic characterization of pesticide-selective F ab fragment variants derived by molecular evolution of variable antibody genes. Analytical and Bioanalytical Chemistry. 372(2). 261–267. 11 indexed citations
14.
Rau, Doris, Karl Kramer, & Bertold Hock. (2002). SINGLE-CHAIN FvANTIBODY-ALKALINE PHOSPHATASE FUSION PROTEINS PRODUCED BY ONE-STEP CLONING AS RAPID DETECTION TOOLS FOR ELISA. Journal of Immunoassay and Immunochemistry. 23(2). 129–143. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026